Topoisomerase II inhibitors. Synthetic hybridization of 4-quinolones and anthracyclines

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 9, 1997, Pages 1097-1100

  Kulkarni, Trupti ^a   Mitscher, Lester A ^a   Shen, Linus L ^a,b   Telikepalli, Hanumiah ^a   Wei, Dong ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 QUINOLONE DERIVATIVE; AMPHOTERICIN B; ANTHRACYCLINE DERIVATIVE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; DNA CLEAVAGE; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; NONHUMAN; TUMOR CELL;

EID: 0031011680     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00191-1     Document Type: Article

References (16)

1. (a) Wang, J. C. In DNA Topoisomerases: Biochemistry and Molecular Biology; Liu, L. F., Ed.; Academic Press: New York, 1994; pp 1-19.
2. (b) Fostel, J. M.; Shen, L. L. In Design of Enzyme Inhibitors as Drugs; Sandler, M.; Smith, H. J., E's.; Oxford University: Oxford, 1994; pp 564-624.
3. (a) Liu, L. F. In DNA Topology and Its Biological Effects, Cozzarelli, N. R.; Wang, J. C., Eds.; Cold Spring Harbor Lab Press: New York, 1990, pp 371-389.
4. (b) Osheroff, N.; Corbett, A. H.; Johnson, M. J. In DNA Topoisomerases: Biochemistry and Molecular Biology: Liu, L. F., Ed.; Academic Press: New York, 1994; pp 105-126.
5. (a) Mitscher, L. A.; Shen, L. L. In Nucleic Acid Targeted Drug Design; Propst, C. L.; Perun, T. J., Eds.; M. Dekker: New York, 1992; pp 423-474.
6. (b) Kato, J.-I.; Ikeda, H. In Molecular Biology of DNA Topoisomerases and its Application to Chemotherapy; Ando, T.; Ikeda, H.; Ogura, M., Eds.; C.R.C.; Boca Raton, 1993; pp 32-37.
7. (c) Shen, L. L.; Baranowski,.J.; Fostel, J.; Montgomery, D. A.; Lartey, P. A. Antimicrob. Agents Chemother. 1992, 36, 2778-2784.
8. (a) Gootz, T. D.; Osheroff, N. In Quinolone Antimicrobial Agents, 2nd Ed; Hooper, D. C.; Wolfson, J. S., Eds.; American Society for Microbiology: New York, 1993, pp 139-160.
9. (b) Sato, K.; Hoshino, K.; Mitsuhashi, S. Prog, Chem. Research. 1992, 38, 121-132.
10. Hahn, D. V.; Sequin, E.; Tillequin, F.; Monneret, C.; Koch, M. Chem Pharm. Bull. 1989, 37, 3294-3300.
11. (a) Marschalk, C.; Koenig, F.; Ouroussoff, N. Bull. Soc. chim. France, 1936, 3, 1545-1555.
12. (b) Marschalk, C. Bull. Soc. chim. France. 1939, 6, 655-665.
13. (a) Grohe, K.; Heitzer, H. Liebig's Ann. Chem., 1987, 29-37.
14. (b) ibid., 871-879.
15. Shen, L. L.; Mitscher, L. A.; Sharma, P.; O'Donnell, T. J.; Chu, D. W. T.; Cooper, C. S.; Rosen, T.; Pernet, A. G. Biochemistry, 1989, 28, 3886-3894.
16. Chu, D. T. W.; Hallas, R.; Clement, J. J.; Alder, J.; McDonald, E.; Plattner, J. J. Drugs Exptl. Clin. Res. 1992, 18, 275-282.